🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7335744

    Prostate cancer specific internalizing human antibodies

    The Regents of the California University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7335382

    Compositions and methods for the treatment and prevention of cancer

    Northwestern University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7332590

    Molecular characteristics of non-small cell lung cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7332287

    Methods and compositions for diagnosing breast cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7332281

    Therapeutic targets in cancer

    Sagres Discovery, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7329759

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7329502

    ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7326734

    Treatment of bladder and urinary tract cancers

    The Regents of the University of California · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7323173

    Methods for treating breast cancer using a mammary cell growth inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7319091

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7317086

    Basal cell carcinoma tumor suppressor protein

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7314731

    Method for selecting therapeutic agents for cancer

    Precision Therapeutics, Inc. · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7309694

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7306914

    Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy

    Odyssey Thera Inc. · Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7291603

    Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

    PTC THERAPEUTICS, INC. · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7285527

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7279294

    Tumor markers in ovarian cancer

    The United States of America as represented by the Secretary, Dept. of Health and Human Services, NIH · Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7270960

    Diagnosis of ovarian carcinomas

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7271161

    Platinum complexes as antitumor agents in combination with biochemical modulation

    The Board of Regents of the University of Texas System · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7264820

    Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline

    The Regents of the University of California · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7256004

    Variants of humanized anti-carcinoma monoclonal antibody CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7250169

    Anti-tumor activity of Ea-4-peptide of pro-IGF-1

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7247316

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7244450

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7238525

    Strategy for leukemia therapy

    The Regents of the University of California · Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7232887

    Melanoma antigens and their use in diagnostic and therapeutic methods

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7229770

    YKL-40 as a marker and prognostic indicator for cancers

    The Regents of the University of California · Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7220730

    Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7217795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7205334

    Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7204996

    Method of cancer treatment

    The Board of Regents of the University of Texas System · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7204982

    Compositions and methods for treatment and detection of multiple cancers

    The Regents of the University of California · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7202045

    Detection and treatment of cancers of the lung

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7192704

    Methods for detection and treatment of neural cancers

    The Regents of the University of California · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7189393

    Recombinant anti-tumor RNAse

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7183388

    Anti-MUC-1 single chain antibodies for tumor targeting

    The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7183389

    Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)

    Molecular Discoveries, Inc. · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7179588

    Assay for the detection of paclitaxel resistant cells in human tumors

    The Board of Regents of the University of Texas System · Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7175830

    Imaging of drug accumulation as a guide to antitumor therapy

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7175981

    Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins

    The United States of America as represented by the Secretary of the Army · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7169384

    Tumor suppressor CAR-1

    The Board of Regents of the University of Texas System · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7166704

    Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7163925

    p16 expression constructs and their application in cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7160868

    Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors

    Northwest Hospital · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7150869

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7151100

    Indole compounds useful for the treatment of cancer

    The Regents of the University of California · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7148196

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.